- The Past, Present and Future of Heart Transplantation
-
Kim IC, Youn JC, Kobashigawa JA
- KMID: 2414892
- Korean Circ J.
- 2018 Jul;48(7):565-590.
- doi: 10.4070/kcj.2018.0189
Heart transplantation (HTx) has become standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-HTx care have resulted in a substantial decrease... -
- CITED
-
- Close
- SHARE
-
- Close
- Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center
-
Chang DH, Youn JC, Dilibero D, Patel JK, Kobashigawa JA
- KMID: 2532589
- Int J Heart Fail.
- 2021 Jan;3(1):15-30.
- doi: 10.36628/ijhf.2020.0034
Heart transplant is the optimal treatment for selected patients with end-stage heart failure. Immunosuppression after heart transplantation has significantly reduced the incidence of rejection and improved patient outcomes with the routine... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes and implications of pretransplant history of malignancy in heart transplant recipient
-
Kim D, Youn JC, Kim JJ, Kim KA, Kim IC, Lee HS, Choi JO, Jeon ES, Kobashigawa JA
- KMID: 2535525
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S298.
- doi: 10.4285/ATW2022.F-4378
Background: The number of patients with prior malignancy needing heart transplant (HTx) is increasing; however, detailed clinical characteristics and long-term clinical outcomes of these patients are largely unknown. We sought... -
- CITED
-
- Close
- SHARE
-
- Close
